Associate
Matthew has had responsibilities in all phases of federal district court litigation and international arbitrations, including taking depositions, managing discovery, working with expert and fact witnesses, developing patent infringement and validity arguments, writing briefs and motions, and defending witnesses at trial. He has represented several branded pharmaceutical companies in Abbreviated New Drug Applications (ANDA) litigations under the Hatch-Waxman Act and in international arbitrations.
Matthew's practice also includes patent prosecution and inter partes review (IPR) before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). Matthew also devotes time to pro-bono matters, representing disabled veterans before the U.S. Court of Appeals for Veterans Claims.
Prior to his legal career, Matthew worked as an instrumentation engineer for Ambitech Engineering in Downers Grove, Illinois, where he provided on-site construction field support and assisted with the specification and procurement of instrumentation for a new polysilicate production plant.
Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.
Member of team representing Dow and Valeant in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic versions of Onexton®.
2:16-cv-00217; 2:17-cv-00544, -01568, D.N.J., Judges Chesler, Waldor
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Member of team representing Valeant in Hatch-Waxman patent infringement litigation concerning an ANDA for generic versions of Cardizem® LA.
3:17-cv-00449, D.N.J., Judges Sheridan, Goodman
Flexsys America L.P. v. Process Engineering Associates LLC
Member of team representing Flexsys in trade secret litigation brought under the Defend Trade Secrets Act (DTSA) and state law relating to client’s proprietary process technology.
3:16-cv-00311, E.D. Tenn., Judges Mattice, Guyton
AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
1:18-cv-00664, D. Del., Judge Andrews
Event
Recent IPR and District Court Litigation in the Life Sciences Recent IPR and District Court Litigation in the Life Sciences
July 12, 2023
Webinar
Event
Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields
September 21, 2022
Webinar
Event
Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners
March 8, 2022
Webinar
Event
Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields
September 28, 2021
Webinar
Media Mention
Litigators of the Week: Shout Out Litigators of the Week: Shout Out
October 22, 2021
The AmLaw Litigation DailyDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.